By Allen St. Pierre, NORML Executive Director We read with interest the recent review of medical use of cannabinoids (1). As the authors attempt to emphasize, they focus on a heterogeneous collection of experiments that employed a range of treatments, including synthetic THC, CBD, and THC-mimicking drugs. Lay readers might inappropriately generalize these results